With significant advancements in heart treatment, the days of open-heart surgery as the only option for complex heart conditions are mostly behind us. Today, minimally invasive procedures can be used ...

BOSTON, MA—(UPDATED) Patients with severe symptomatic degenerative mitral regurgitation (MR) ineligible for surgery fare just as well when treated with the Pascal device (Edwards Lifesciences) as ...

Abbott Laboratories, Inc. ABT recently presented late-breaking data from the Landmark COAPT trial for MitraClip, demonstrating the long-term benefits of the device in patients fighting heart failure.

In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as “Dr.

Doctors at the Asian Institute of Medical Sciences (AIMS), Faridabad, have successfully performed a first-of-its-kind Transcatheter mitral valve repair (Mitraclip) on an 80-year-old woman with severe ...

ABBOTT PARK, Ill., March 20, 2013 /PRNewswire/ --Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory ...

SAN DIEGO, CA—When it comes to treating mitral valve disease, several leaders of the field at the Society of Thoracic Surgeons (STS) annual meeting urged their peers to take up transcatheter ...

On February 15, FDA announced that Abbott Vascular has received nine reports of its MitraClip delivery system failing to detach from the Clip, which resulted in the death of one patient and open-heart ...

When Murray Norman started having trouble breathing in the fall of 2020, he and his wife, Joyce, never expected it to be serious enough that he might need surgery for a leaky heart valve. The problem ...

The US Food and Drug Administration is alerting healthcare providers about the potential for clip lock malfunctions with Abbott's MitraClip's delivery system. "These events appear to occur in ...